BSEGeneral1h ago · 3 Oct 2026, 06:35 pm
Compliance -57(5) Intimation after the end of quarter
Transgene Biotek Ltd · 526139
✦ AI SummaryRegulatory
Transgene Biotek Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended September 30, 2026, as no non-convertible securities were issued.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Transgene Biotek Ltd - 526139 - Compliance-57 (5) : intimation after the end of quarter
Attachments (1)
📄pdf
Download →
5a44afa5-8b72-4401-bd5a-7ec8f3875060.pdf
View document text
Date 03-10-2026
The General Manager
Department of Corporate Services – CRD
BSE LIMITED Phiroze Jeejeebhoy Towers
Dalal Street,Mumbai 400 001.
Subject: Non-Applicability of Reg. 57(5) of SEBI (LODR) Regulations,
2015.
As per the Captioned Subject, we hereby inform you that Company has not issued
any Non-Convertible Securities. So, the Regulation 57(5) of SEBI (LODR) Regulation,
2015 is Not Applicable to the Company for the Quarter ended as on 30th September
2026.
Compliance Remarks
A certificate confirming the payment of Not Applicable
interest/dividend/principal obligations for
nonconvertible securities which were due
in that quarter;
The details of all unpaid Not Applicable
interest/dividend/principal obligations in
relation to non-convertible securities at
the end of the quarter
We kindly request you to take the above said on record.
Thanking You,
Yours faithfully
For TRANSGENE BIOTEK LIMITED
DR K KOTESWARA RAO
CHAIRMAN & MANAGING DIRECTOR
Plot 69 & 70 IDA Bollaram, Sangareddy District – 502 325, Telangana, India
Ph: +91-40-65589499 Fax: +91-8458-279755 Web: www.transgenebiotek.com
Email: info@transgenebiotek.com, CIN No: L85195AP1990PLC011065